Compounds > imipramine

imipramine and memantine

imipramine has been researched along with memantine in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (7.69)	18.2507
2000's	4 (30.77)	29.6817
2010's	7 (53.85)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Glen, RC; Lowe, R; Mitchell, JB	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Andrisano, V; Barniol-Xicota, M; Bartolini, M; De Simone, A; Espargaró, A; Muñoz-Torrero, D; Pérez, B; Pérez-Areales, FJ; Pivetta, D; Pont, C; Sabate, R; Sureda, FX; Turcu, AL; Vázquez, S	1
Brea, JM; Companys-Alemany, J; Griñán-Ferré, C; Johnson, JW; Kurnikova, MG; Loza, MI; Pallàs, M; Patel, DS; Pérez, B; Phillips, MB; Soto, D; Sureda, FX; Turcu, AL; Vázquez, S	1
Fujii, A; Nakata, Y; Nishio, H	1
Budziszewska, B; Jaworska-Feil, L; Kajta, M; Lasoń, W	1
Fries, GR; Kapczinski, F; Kirsch, TR; Quevedo, J; Réus, GZ; Roesler, R; Stringari, RB	1
Benedet, J; Daufenbach, JF; Fraga, DB; Quevedo, J; Réus, GZ; Rezin, GT; Rochi, N; Scaini, G; Streck, EL; Stringari, RB	1
Canu, D; Demontis, F; Falconi, M; Serra, G	1
Gawel, K; Gibula-Bruzda, E; Jenda, M; Kotlinska, JH; Marszalek-Grabska, M	1

Reviews

1 review(s) available for imipramine and memantine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

12 other study(ies) available for imipramine and memantine

Article	Year
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors. European journal of medicinal chemistry, 2019, Oct-15, Volume: 180 Topics: Acetylcholinesterase; Adamantane; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Tacrine	2019
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease. European journal of medicinal chemistry, 2022, Jun-05, Volume: 236 Topics: Alzheimer Disease; Animals; Caenorhabditis elegans; Disease Models, Animal; Memantine; Mice; Receptors, N-Methyl-D-Aspartate	2022
Re-examination for pharmacological properties of serotonin-induced tachycardia in isolated guinea-pig atrium. Behavioural brain research, 1996, Volume: 73, Issue:1-2 Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Excitatory Amino Acid Antagonists; Guinea Pigs; Heart; Heart Atria; Heart Rate; Imipramine; In Vitro Techniques; Male; Memantine; Myocardial Contraction; Propranolol; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists	1996
Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism. British journal of pharmacology, 2000, Volume: 130, Issue:6 Topics: Amantadine; Animals; Antidepressive Agents; Cell Line, Transformed; Chloramphenicol O-Acetyltransferase; Cocaine; Corticosterone; Cyclic AMP; Cyclic GMP; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrenes; Gene Expression Regulation; Imipramine; Lithium Chloride; Memantine; Mifepristone; Protein Kinase Inhibitors; Pyrrolidinones; Receptors, Glucocorticoid; Receptors, Steroid; Sulfonamides; Tamoxifen; Thionucleotides; Time Factors; Transcription, Genetic; Type C Phospholipases	2000
Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Brain research bulletin, 2010, Apr-05, Volume: 81, Issue:6 Topics: Animals; Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Depressive Disorder; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hippocampus; Imipramine; Locomotion; Male; Memantine; Motor Activity; N-Methylaspartate; Neuropsychological Tests; Rats; Rats, Wistar; Swimming; Time Factors	2010
Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain. Journal of neural transmission (Vienna, Austria : 1996), 2012, Volume: 119, Issue:4 Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Brain; Creatine Kinase; Dopamine Agents; Dose-Response Relationship, Drug; Imipramine; Male; Memantine; Multienzyme Complexes; NADH Dehydrogenase; Rats; Rats, Wistar; Time Factors	2012
Memantine prevents "bipolar-like" behavior induced by chronic treatment with imipramine in rats. European journal of pharmacology, 2015, Apr-05, Volume: 752 Topics: Animals; Antidepressive Agents; Behavior, Animal; Bipolar Disorder; Depression; Imipramine; Male; Memantine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Swimming; Time Factors	2015
Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats. Brain research, 2016, 07-01, Volume: 1642 Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Antidepressive Agents; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Imipramine; Male; Memantine; Memory Disorders; Muscarinic Antagonists; Nootropic Agents; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Scopolamine; Substance Withdrawal Syndrome	2016